Empowered by Genetic Testing: How MyRisk® Hereditary Cancer Testing Helps Take Preventive Measures May 25, 2023 Larry underwent a radical prostatectomy when he was first diagnosed with prostate cancer at age 62. Although the surgery was successful in removing the cancer,... Continue Reading
Detecting more prostate cancer earlier with PSMA PET Scans May 24, 2023 Prostate cancer doesn't always require aggressive treatment. Most men can delay complex treatment until necessary through Active Surveillance according to a ne... Continue Reading
Understanding Prostate Cancer: A Guide for Men and Their Loved Ones May 1, 2023 Prostate cancer is a very common disease, roughly 1 in 8 American men will be diagnosed with prostate cancer during their lifetime. Receiving a prostate cancer... Continue Reading
Healthcare Hero: Kara Cossis, Chesapeake Urology April 12, 2023 At Myriad Genetics, our mission is to advance health and well-being for all, and a big component of that is developing reliable, accessible genetic tests for a... Continue Reading
Medical Experts Discuss Benefits of Genetic Testing in Prostate Cancer Care March 23, 2023 In a recent Myriad Live webinar, our Chief Medical Officer, Thomas Slavin, hosted a lively conversation about prostate cancer with two experts from the field: ... Continue Reading
Prostate Cancer Proactive Healthcare Steps March 17, 2023 Author: Geoff McLennan, prostate cancer patient and advocate Every January since 1951 the American Cancer Society (ACS) has published an annual report about... Continue Reading
Expanding access to PARP inhibitors in prostate cancer treatment March 14, 2023 Last month, Myriad attended the 2023 ASCO Genitourinary Cancers Symposium (ASCO GU) to connect with researchers and doctors around emergent and controversial a... Continue Reading
Personalized Prostate Cancer Treatment: The Role of the Prolaris® Test March 10, 2023 Prostate cancer is a common cancer affecting men, and historically the most common approach to treatment would be either surgery or radiation therapy. However,... Continue Reading
American Cancer Society® Reports Increase in Late-Stage Prostate Cancer February 3, 2023 Amid the great news reported recently by the American Cancer Society — that overall deaths from cancer have dropped by a third since 1991, saving nearly 4 mi... Continue Reading
How is the Prostate Gleason Score Graded? Your Biopsy and Gleason Score Part 2 February 1, 2023 Geoff McLennan, Prostate Cancer Survivor and Advocate In part one of this blog series, I explained the different types of prostate biopsies available ... Continue Reading
Types of Prostate Biopsies: Your biopsy and Gleason score Part 1 January 23, 2023 Geoff McLennan, Prostate Cancer Survivor and Advocate A urologist will usually, but not always, suggest a biopsy of your prostate when there is reason ... Continue Reading
Prostate cancer can be hereditary, get peace of mind with Myriad Genetic Testing January 13, 2023 https://myriad-1.wistia.com/medias/yff9ux0rmk When Tim Petracca was diagnosed with prostate cancer at age 63, he began to think about his extensive fa... Continue Reading
Patient PSA Test Primer: Best times to test and how to prepare January 6, 2023 Geoff McLennan, Prostate Cancer Survivor and Advocate As men enter, or race, into middle-age, and their doctors add another level of care, the first of ma... Continue Reading
Prolaris® provides clarity for prostate cancer treatment decisions. A patient story. December 12, 2022 https://myriad-1.wistia.com/medias/70m1vw0uka Elevated PSA levels warning Tim Petracca was a healthy 63-year-old when he attended a regularly sched... Continue Reading
Patient Prostate Cancer Journey Part 3: Shared Decision-Making Benefits to Prostate Cancer Treatment December 1, 2022 A transparent, confident relationship with your urologist is important not only for your current health, but for your future health outcomes. The good new... Continue Reading